Morningstar Investor users sign in here.

Company Profile

  • Business description

    MorphoSys AG is a biopharmaceutical company dedicated to the discovery, development and commercialization of therapies for people living with cancer and autoimmune diseases. MorphoSys is advancing its own pipeline of new drug candidates and has created antibodies that are developed by partners in different areas of unmet medical need. Tremfya (guselkumab) - developed by Janssen Research & Development, LLC and marketed by Janssen Biotech, Inc. for the treatment of plaque psoriasis - became the first drug based on MorphoSys antibody technology to receive regulatory approval. The U.S. Food and Drug Administration granted accelerated approval of the company's proprietary product Monjuvi (tafasitamab-cxix) in combination with lenalidomide for patients with a certain type of lymphoma.

  • Contact

    Semmelweisstrasse 7
    Planegg BY 82152
    DEU

    T: +49 89899270

    E: investors@morphosys.com

    https://www.morphosys.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2024

    Employees

    464

Stocks News & Analysis

stocks

Surge in ASX share may be overblown

After an acquisition bid for Premier’s Apparel Brands business Myer shares soared but the combination may exacerbate existing risk to the business.  
stocks

3 cheap Wide Moat stocks in a divided industry

All but a couple of shares in this industry have sold off. Our analysts think these three high quality companies have fallen too far. 
stocks

3 industries to focus on for high quality investments

Some industries are moaty by nature. One that is deeply out of favour offers a prime example.

Markets

Index
Last price
Change
% Change
All Ordinaries 8,030.50 55.40 0.69%
CAC 40 7,706.89 78.32 1.03%
DAX 40 18,325.58 162.06 0.89%
Dow JONES (US) 39,411.21 260.88 0.67%
FTSE 100 8,281.55 43.83 0.53%
HKSE 18,088.02 60.31 0.33%
NASDAQ 17,496.82 192.54 -1.09%
Nikkei 225 38,822.56 17.91 0.05%
NZX 50 Index 11,620.19 7.67 -0.07%
S&P 500 5,447.87 16.75 -0.31%
S&P/ASX 200 7,792.20 58.50 0.76%
SSE Composite Index 2,962.76 0.34 -0.01%

Market Movers

Name
Last price
Change
% Change
Red 5 Ltd RED 0.38 0.03 -7.32%
Patriot Battery Metals Inc PMT 0.58 0.03 5.91%
Core Lithium Ltd CXO 0.08 0.00 1.27%
Imugene Ltd IMU 0.06 0.00 0.91%
Pilbara Minerals Ltd PLS 3.15 0.04 1.13%
Liontown Resources Ltd LTR 0.92 0.01 0.82%
Cettire Ltd CTT 1.11 0.03 -2.20%
Bellevue Gold Ltd BGL 1.75 0.02 1.16%
Melbana Energy Ltd MAY 0.04 0.00 5.00%
Lake Resources NL LKE 0.04 0.00 -6.82%